Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 223

1.

A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial.

Stebbins A, Mehta RH, Armstrong PW, Lee KL, Hamm C, Van de Werf F, James S, Toftegaard-Nielsen T, Seabra-Gomes R, White HD, Granger CB; Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI Investigators)..

Circ Cardiovasc Interv. 2010 Oct;3(5):414-22. doi: 10.1161/CIRCINTERVENTIONS.109.925180.

2.

Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction".

French JK, Armstrong PW, Cohen E, Kleiman NS, O'Connor CM, Hellkamp AS, Stebbins A, Holmes DR, Hochman JS, Granger CB, Mahaffey KW.

Am Heart J. 2011 Jul;162(1):89-97. doi: 10.1016/j.ahj.2011.04.009.

PMID:
21742094
3.
4.

ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.

Buller CE, Fu Y, Mahaffey KW, Todaro TG, Adams P, Westerhout CM, White HD, van 't Hof AW, Van de Werf FJ, Wagner GS, Granger CB, Armstrong PW.

Circulation. 2008 Sep 23;118(13):1335-46. doi: 10.1161/CIRCULATIONAHA.108.767772.

5.

Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.

Hudson MP, Armstrong PW, O'Neil WW, Stebbins AL, Weaver WD, Widimsky P, Aylward PE, Ruzyllo W, Holmes D, Mahaffey KW, Granger CB.

Circ Cardiovasc Qual Outcomes. 2011 Mar;4(2):183-92. doi: 10.1161/CIRCOUTCOMES.110.945311.

6.

Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarction.

Tjandrawidjaja MC, Fu Y, Westerhout CM, White HD, Todaro TG, Van de Werf F, Mahaffey KW, Wagner GS, Granger CB, Armstrong PW; APEX-AMI Investigators..

Eur Heart J. 2010 Mar;31(5):573-81. doi: 10.1093/eurheartj/ehp494.

PMID:
19952006
7.

Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.

Maeng M, Nielsen PH, Busk M, Mortensen LS, Kristensen SD, Nielsen TT, Andersen HR; DANAMI-2 Investigators..

Am J Cardiol. 2010 Jun 1;105(11):1528-34. doi: 10.1016/j.amjcard.2010.01.005.

PMID:
20494656
8.

Prediction of 1-year mortality with different measures of ST-segment recovery in all-comers after primary percutaneous coronary intervention for acute myocardial infarction.

Verouden NJ, Haeck JD, Kuijt WJ, van Geloven N, Koch KT, Henriques JP, Baan J, Vis MM, Piek JJ, Tijssen JG, de Winter RJ.

Circ Cardiovasc Qual Outcomes. 2010 Sep;3(5):522-9. doi: 10.1161/CIRCOUTCOMES.109.923797.

9.

Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study.

Bagai A, Armstrong PW, Stebbins A, Mahaffey KW, Hochman JS, Weaver WD, Patel MR, Granger CB, Lopes RD.

Am Heart J. 2013 Nov;166(5):913-9. doi: 10.1016/j.ahj.2013.08.006.

PMID:
24176448
10.
11.

Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry.

Kalińczuk Ł, Przyłuski J, Karcz M, Petryka J, Kaczmarska E, Bekta P, Kepka C, Kruk M, Pregowski J, Kadziela J, Deptuch T, Skwarek M, Cedro K, Ciszewski M, Debski A, Ciszewski A, Chmielak Z, Demkow M, Witkowski A, Ruzyłło W.

Kardiol Pol. 2007 Jan;65(1):1-10; discussion 11-2. English, Polish.

12.

Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.

Ezekowitz JA, Armstrong PW, Granger CB, Theroux P, Stebbins A, Kim RJ, Patel MR.

Am Heart J. 2010 Aug;160(2):272-8. doi: 10.1016/j.ahj.2010.05.035.

PMID:
20691832
14.

Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.

Damman P, Beijk MA, Kuijt WJ, Verouden NJ, van Geloven N, Henriques JP, Baan J, Vis MM, Meuwissen M, van Straalen JP, Fischer J, Koch KT, Piek JJ, Tijssen JG, de Winter RJ.

J Am Coll Cardiol. 2011 Jan 4;57(1):29-36. doi: 10.1016/j.jacc.2010.06.053. Erratum in: J Am Coll Cardiol. 2011 Apr 19;57(16):1717-9.

15.

Diagnosing acute myocardial infarction in patients with left bundle branch block.

Lopes RD, Siha H, Fu Y, Mehta RH, Patel MR, Armstrong PW, Granger CB.

Am J Cardiol. 2011 Sep 15;108(6):782-8. doi: 10.1016/j.amjcard.2011.05.006.

PMID:
21726838
16.

Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Tjandrawidjaja MC, Fu Y, Westerhout CM, Wagner GS, Granger CB, Armstrong PW; APEX-AMI Investigators..

Am J Cardiol. 2010 Sep 1;106(5):630-4. doi: 10.1016/j.amjcard.2010.04.013.

PMID:
20723636
17.

Relative prognostic value of baseline Q wave and time from symptom onset among men and women with ST-elevation myocardial infarction undergoing percutaneous coronary intervention.

Kaul P, Fu Y, Westerhout CM, Granger CB, Armstrong PW.

Am J Cardiol. 2012 Dec 1;110(11):1555-60. doi: 10.1016/j.amjcard.2012.07.020.

PMID:
22920928
18.

Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction.

Mills JS, Mahaffey KW, Lokhnygina Y, Nicolau JC, Ruzyllo W, Adams PX, Todaro TG, Armstrong PW, Granger CB; CARDINAL investigators..

Coron Artery Dis. 2012 Mar;23(2):118-25. doi: 10.1097/MCA.0b013e32834e4f8f.

PMID:
22217457
19.

Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI).

Danchin N, Coste P, Ferrières J, Steg PG, Cottin Y, Blanchard D, Belle L, Ritz B, Kirkorian G, Angioi M, Sans P, Charbonnier B, Eltchaninoff H, Guéret P, Khalife K, Asseman P, Puel J, Goldstein P, Cambou JP, Simon T; FAST-MI Investigators..

Circulation. 2008 Jul 15;118(3):268-76. doi: 10.1161/CIRCULATIONAHA.107.762765.

20.

Relation between electrocardiographic ST-segment resolution and early and late outcomes after primary percutaneous coronary intervention for acute myocardial infarction.

Brodie BR, Stuckey TD, Hansen C, VerSteeg DS, Muncy DB, Moore S, Gupta N, Downey WE.

Am J Cardiol. 2005 Feb 1;95(3):343-8.

PMID:
15670542
Items per page

Supplemental Content

Support Center